Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer

R. Connor Chick, G. Travis Clifton, Diane F. Hale, Timothy J. Vreeland, Annelies T. Hickerson, Phillip M. Kemp Bohan, Patrick M. McCarthy, Jennifer K. Litton, Gheath Alatrash, Rashmi K. Murthy, Na Qiao, Anne Philips, Jason Lukas, Jarrod P. Holmes, Elizabeth A. Mittendorf, George E. Peoples

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences